IVAX, Omnicare settle kickback allegations regarding Risperdal
IVAX Pharmaceuticals and Omnicare agreed to resolve allegations that they solicited kickbacks in exchange for encouraging doctors to prescribe Johnson & Johnson's antipsychotic Risperdal to patients at nursing homes, the Justice Department said. Omnicare, which will pay $98 million, denied wrongdoing despite the settlement.
Reuters
| 11/3
This story published in FMI Pharmacy dailyLead on 11/04/2009
Get stories like these delivered daily for FREE:
|
FMI Pharmacy dailyLead
Designed specifically for pharmacy professionals, FMI Pharmacy dailyLead is a FREE, daily e-mail newsletter. It provides the latest news in the pharmacy arena. Learn more |
|